Showing results (171-180 of 220) with videos related to
Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|June 25, 2014
Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205Yasuhiro Shimada, Tetsuya Hamaguchi, Junki Mizusawa, et al.Japanese Journal of Clinical Oncology|December 5, 2021
Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212)Masayuki Ohue, Shin Fujita, Junki Mizusawa, et al.Cancer Immunology Research|May 20, 2016
Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer PatientsKohei Tada, Shigehisa Kitano, Hirokazu Shoji, et al.Journal of Gastrointestinal Cancer|March 23, 2021
Verification of the Utility of Palliative Radiotherapy for Hemostasis of Gastric Cancer Bleeding: a Case Control StudyHirofumi Sugita, Shinichi Sakuramoto, Yoshiaki Mihara, et al.Drug Metabolism and Pharmacokinetics|May 17, 2006
Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese populationKeiko Maekawa, Masaya Itoda, Kimie Sai, et al.Cancer Science|May 25, 2010
Plasma concentrations of VCAM-1 and PAI-1: a predictive biomarker for post-operative recurrence in colorectal cancerYasuhide Yamada, Tokuzo Arao, Kazuko Matsumoto, et al.Japanese Journal of Clinical Oncology|March 3, 2020
Challenges of improving treatment outcomes for colorectal and anal cancers in Japan: the Colorectal Cancer Study Group (CCSG) of the Japan Clinical Oncology Group (JCOG)Akira Ouchi, Dai Shida, Tetsuya Hamaguchi, et al.Annals of Surgery|February 7, 2022
The Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006): A Multicenter, Open-label, Randomized, Phase III TrialYasumasa Takii, Junki Mizusawa, Yukihide Kanemitsu, et al.Cancer Chemotherapy and Pharmacology|November 10, 2007
Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patientsKimie Sai, Yoshiro Saito, Hiromi Fukushima-Uesaka, et al.Japanese Journal of Clinical Oncology|May 22, 2025
Protocol digest of a single-arm confirmatory trial for less intensive postoperative surveillance in low-risk colorectal cancer patients: JCOG1915 (less study)Yuta Sekino, Konosuke Moritani, Junki Mizusawa, et al.Pageof 22